Eric Xue
Senior Director, Real-world Evidence Incyte Corporation
Zhenyi (Eric) Xue is a Sr. Director of RWE Statistics at Incyte Corporation in Wilmington, DE. Prior to joining Incyte in 2022, Eric spent almost 20 years in academia, medical devices, and pharmaceutical companies for life science research. He has worked at Howard University, MedStar Health, Becton Dickinson and Company, and AbbVie with increasing responsibilities. He is a co-author of >150 publications ranging across various therapeutic areas. He holds a PhD in Applied Statistics from University of Maryland, a MS in Biostatistics from University of Minnesota, and a MS in Biochemistry and Molecular Biology from Chinese Academy of Sciences.
Seminars
This interactive workshop brings together leaders across epidemiology, biostatistics, HEOR, and market access to examine where RWE breaks down in practice, and how to design evidence that consistently delivers decision impact.
This workshop will gather experts to discuss:
- Identifying where RWE fails to translate into regulatory, payer, and clinical decisions despite strong methodology
- Understanding how different stakeholders interpret uncertainty, bias and evidence strength, and why alignment breaks down even with high-quality data
- Balancing data complexity with clarity by ensuring analytical approaches, including advanced methods and AI, remaining interpretable and decision‑relevant
- Applying statistical and epidemiological rigor to improve comparability, mitigate bias, and ensure outputs are credible across use cases
- Designing evidence strategies earlier in development that align with downstream
decision needs to reduce rework, delays, and missed impact
